Labopharm Inc. (NASDAQ: DDSS) today announced the results of its recently completed North American Phase III clinical trial for its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE